STOCK TITAN

GRTX Form 144: Notice of 70,000-share insider stock sale

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

GRTX has a Form 144 notice indicating that an affiliate plans to sell up to 70,000 shares of common stock through Raymond James & Associates on the OTC Markets, with an approximate sale date of 11/20/2025 and an aggregate market value of 1400.00. The table lists 75,462,390 shares of the issuer’s stock as outstanding, providing context for the planned sale size. The seller originally acquired 217,015 common shares on 03/06/2021 via a stock option exercise paid in cash. By signing the notice, the seller represents that they are not aware of any material adverse, non‑public information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the GRTX Form 144 filing disclose?

The Form 144 filing for GRTX discloses that an affiliate of the company intends to sell up to 70,000 shares of common stock under Rule 144, providing notice of a planned resale of restricted or control securities.

How many GRTX shares are planned to be sold and at what value?

The notice states that up to 70,000 common shares of GRTX are to be sold, with an aggregate market value of approximately 1400.00 as shown in the table.

When is the planned sale date and where will the GRTX shares trade?

The filing lists an approximate date of sale of 11/20/2025, with the shares to be sold on the OTC Markets through Raymond James & Associates.

How were the GRTX shares being sold originally acquired?

The securities table shows that 217,015 common shares were acquired on 03/06/2021 via a stock option exercise from the issuer, with the purchase price paid in cash.

How many GRTX shares are listed as outstanding in this filing?

The Form 144 table lists 75,462,390 shares of GRTX common stock as outstanding, giving context for the relative size of the planned 70,000‑share sale.

Does the GRTX Form 144 mention undisclosed negative information?

The signer represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as part of the Form 144 certification.

Galera Therapeutics, Inc.

OTC:GRTX

GRTX Rankings

GRTX Latest News

GRTX Latest SEC Filings

GRTX Stock Data

6.52M
50.79M
32.84%
9.99%
3.9%
Biotechnology
Pharmaceutical Preparations
Link
United States
MALVERN